Investment Q&A

Q: do you feel a 50% dividend cut is priced in

Q: I would like to add a comment in response to the question on Manulife's Income for Life offer from Dave. I am a financial advisor who recently dealt with this issue with an inherited client who had both a registered and non-registered Income for Life product. Some considerations to keep in mind is that the "top up" offer for non-registered plans is fully taxable. In my client's case, we determined that the non-registered offer didn't make sense but that the one for the registered plan did, as there was no taxation and it does not affect the client's RRSP contribution room. In my experience, when an insurance company wants to get out of a product, take a hard look at it because it usually means it is favouring the client too much (but not always, of course). Income for Life is meant to provide not only income for life but guranteed growth in the base amount as well. In Dave's case, the low growth in his capital to date is because of the investments he chose to be in - there is a wide range of investment choices so if the time frame is long enough, he may be able to grow that value. These products are not for everyone but the offer should be examined carefully with the taxation issue in mind. Hope this helps.

Paul F.

Q: Hello, I would like to start a Share Purchase Plan with one of the main banks in Canada. I am not an employee, and would like to do this in an RRSP/TFSA/RESP. I contacted Computershare to do this and they told me it cannot be in done in a registered account. Does anyone know if this can be done any other way or with another company?


Thanks

Q: May I please have your opinion. Thank you.

Q: Odonate Therapeutics - May I please have your opinion on this stock? It looks like insiders own a large chunk of the company and keep buying. Thank you.

Q: What would the beta be of the B.E. portfolio versus the TSX?

Q: Hi, SIS has added a significant amount of long term debt over the last 4 years, and free cash flow seems to have hit a plateau, with a lot of cash coming from financing. Do you feel the growth by acquisition story here looks sustainable?

Q: Is the income portfolio designed to ride out a recession without major changes?

Q: May I have your opinion please. Thank you.

Q: I’m curious about IFOS. A guest on BNN recently described it as a smaller but more promising alternative to NTR. It’s selling for about $1 as I write this but it used to trade close to $400 per share. I certainly wouldn’t mind owning a 400-bagger, if possible, but before I step in I’d like to know what caused the overwhelming loss of value as well as your general opinion on this company and its outlook. It hasn’t stopped falling in price and the P/E is only around 2 (according to Google). Isn't it a red flag when the multiple is so low?

Also, the guest said that NTR wouldn’t do well in a recession and I’m wondering why and whether the same would be true of IFOS.

Please deduct as many credits as necessary. Thanks very much for your comments.

Q: What are you thoughts about Aphria after all the news coming out?

Q: Would you please provide your comments/thoughts on this Limited Partnership ETF. The yield is quite attractive and it seems to contain some quality names. Additionally, could you please provide some insight as to what the tax implications would be, if kept in an RRSP.

Thanks,
David

Q: May I have your opinion please. Thank you.

Q: I have significant losses on above names in my TFSA (Loss, Allocation, My Avg Price):
TSGI -49.20% , 7.10% , $49.48
WCP -47.83% , 1.70%, $. 8.70
WEF - 30.85% , 2.3 % , $. 2.62
NFI. -30.30% , 2.8 % , $. 51.81
PBH. -28.23% , 5.0% , $11.46
Other names in TFSA well diversified based on 5i Balanced portfolio with losses under 10% and some with gains.
Would you recommend buy to average down or any other changes.

Thanks in advance for your valuable advice

Q: Greetings,

Cenovus just reported. What are your thoughts?

Merry Christmas!

Q: Hi
Please help me understand this. What is the net difference between $1 in dividend from an eligible Cdn. company ( eg. ENB) vs. $1 “ dividend “ ( dividend and ROC) from a pure play Cdn. ETF ( eg. ZWU) ? Assume a non- Registerred Account that pays no tax.

Q: Given the current volatility in the market there are a lot of analysts heads making bold predictions. Recently I heard one analyst say that "historically double peaks in a period of heightened volatility signals the end of a bull market". You've taught me there is always an opposing view-so is this statement simply that or is there some credence to it. Thanks for all you do.

Glen

Q: Hello Peter,
There have been many short sellers in the last few years in health care and now in Cannabis stocks. At this point, time will tell on Aphria, but for others like Valeant etc the short sellers were correct. I find it interesting that the brokerage firms, and analyst that covered these companies gave high marks and all of a sudden with a short report, they either revised their price targets or put out a release that the stock is under review rather than defend their own analysis. I am starting to question the analysis that is done by Canadian firms and their ratings. How is it that the short sellers are able to find things that the analysts covering these companies have not managed to even come across? Can you please comment as this is getting ridiculous when analysts and BNN Guests talk highly of companies and than we find out the shortfalls in these companies. Where is the accountability on these analysts and brokerage firms that put out good reports? Thanks very much

Q: THIS STOCK PAY VERY HIGH DIVIDEND( 19% )
YOUR COMMENT FOR RRSP.THANKS

Q: With the 10/2 year treasuries spread now at 0.11 for December 4, 2018. Would it be prudent eye up good quality stocks, in preparation of a recession coming?
And is this something you are watching?